Reported Apr 21, 2021 · Terminated
Cefprozil for Oral Suspension USP, 250mg/5mL, packaged as a) 50 mL (when mixed) bottles (NDC 68180-402-01); b) 75 mL…
Lupin Pharmaceuticals Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Lupin Pharmaceuticals Inc. · Harborplace Tower · Baltimore, MD · 21202-6174
Is this the product you have?
3 of 3 products
| # | Product as published |
|---|---|
| 1 | 50 mL (when mixed) bottles (NDC 68180-402-01) |
| 2 | 75 mL (when mixed) bottles (NDC 68180-402-02); and |
| 3 | 100 mL (when mixed) bottles (NDC 68180-402-03); Rx only, Manufactured for: Lupin Pharmaceutical, Inc., Baltimore, MD 21202; Manufactured by: Lupin Limited, Mandideep 462 046, India. |
- Lot codes and dates
- Lot Numbers
a) F801122exp. date June 2021b) F801123exp. date June 2021c) F801124exp. date June 2021
- Lot Numbers
- Amount recalled
- a) 6,816 bottles; b) 3,960 bottles and c) 7,038 bottles
Where it was sold
- Nationwide
- PR
Why it was recalled
Superpotent Drug
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Lupin Pharmaceuticals Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.